Literature DB >> 24833852

Metabolic consequences of Helicobacter pylori infection and eradication.

György Miklós Buzás1.   

Abstract

Helicobacter pylori (H. pylori) is still the most prevalent infection of the world. Colonization of the stomach by this agent will invariably induce chronic gastritis which is a low-grade inflammatory state leading to local complications (peptic ulcer, gastric cancer, lymphoma) and remote manifestations. While H. pylori does not enter circulation, these extragastric manifestations are probably mediated by the cytokines and acute phase proteins produced by the inflammed mucosa. The epidemiologic link between the H. pylori infection and metabolic changes is inconstant and controversial. Growth delay was described mainly in low-income regions with high prevalence of the infection, where probably other nutritional and social factors contribute to it. The timely eradication of the infection will lead to a more healthy development of the young population, along with preventing peptic ulcers and gastric cancer An increase of total, low density lipoprotein and high density liporotein cholesterol levels in some infected people creates an atherogenic lipid profile which could promote atherosclerosis with its complications, myocardial infarction, stroke and peripheral vascular disease. Well designed and adequately powered long-term studies are required to see whether eradication of the infection will prevent these conditions. In case of glucose metabolism, the most consistent association was found between H. pylori and insulin resistance: again, proof that eradication prevents this common metabolic disturbance is expected. The results of eradication with standard regimens in diabetics are significantly worse than in non-diabetic patients, thus, more active regimens must be found to obtain better results. Successful eradication itself led to an increase of body mass index and cholesterol levels in some populations, while in others no such changes were encountered. Uncertainities of the metabolic consequences of H. pylori infection must be clarified in the future.

Entities:  

Keywords:  Cytokines; Diabetes mellitus; Glucose homeostasis; Growth; Helicobacter pylori; Interleukins; Lipid metabolism; Metabolic syndrome

Mesh:

Substances:

Year:  2014        PMID: 24833852      PMCID: PMC4017037          DOI: 10.3748/wjg.v20.i18.5226

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  78 in total

1.  Association between Helicobacter pylori infection and adult height.

Authors:  Paul Moayyedi; David Forman; Sara Duffett; Su Mason; Julia Brown; Will Crocombe; Richard Feltbower; Anthony Axon
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 2.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis.

Authors:  Vincenzo Pasceri; Giuseppe Patti; Giovanni Cammarota; Christian Pristipino; Giuseppe Richichi; Germano Di Sciascio
Journal:  Am Heart J       Date:  2006-06       Impact factor: 4.749

4.  Helicobacter pylori infection and fasting plasma glucose concentration.

Authors:  H G Peach; N E Barnett
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

5.  Five- to 7-year-old children with Helicobacter pylori infection are smaller than Helicobacter-negative children: a cross-sectional population-based study of 3,315 children.

Authors:  T Richter; T Richter; S List; D M Müller; J Deutscher; H H Uhlig; P Krumbiegel; O Herbarth; F J Gutsmuths; W Kiess
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-10       Impact factor: 2.839

6.  Impact of H. pylori on growth: is the infection or mucosal disease related to growth impairment?

Authors:  Mahir Gulcan; Ahmet Ozen; Hande Ozgun Karatepe; Didem Gulcu; Ayca Vitrinel
Journal:  Dig Dis Sci       Date:  2010-01-29       Impact factor: 3.199

7.  Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines.

Authors:  Jean Louis Georges; Hans J Rupprecht; Stefan Blankenberg; Odette Poirier; Christoph Bickel; Gerd Hafner; Viviane Nicaud; Jürgen Meyer; François Cambien; Laurence Tiret
Journal:  Am J Cardiol       Date:  2003-09-01       Impact factor: 2.778

8.  Effect of Helicobacter pylori eradication in the glycemia of children with type 1 diabetes: a preliminary study.

Authors:  Rodolfo E Bégué; Ricardo Gómez; Terry Compton; Alfonso Vargas
Journal:  South Med J       Date:  2002-08       Impact factor: 0.954

9.  Helicobacter pylori infection is associated with elevated low density lipoprotein cholesterol levels in elderly Koreans.

Authors:  Hack-Lyoung Kim; Han Ho Jeon; In Young Park; Jin Man Choi; Ji Sun Kang; Kyueng-Whan Min
Journal:  J Korean Med Sci       Date:  2011-04-21       Impact factor: 2.153

10.  The interleukin-17 receptor B subunit is essential for the Th2 response to Helicobacter pylori, but not for control of bacterial burden.

Authors:  Dennis J Horvath; Jana N Radin; Sung Hoon Cho; M Kay Washington; Holly M Scott Algood
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

View more
  34 in total

1.  Serologically Determined Gastric Mucosal Condition Is a Predictive Factor for Osteoporosis in Japanese Men.

Authors:  Shigeto Mizuno; Daisuke Matsui; Isao Watanabe; Etsuko Ozaki; Nagato Kuriyama; Yoshiyuki Watanabe
Journal:  Dig Dis Sci       Date:  2015-02-08       Impact factor: 3.199

Review 2.  Helicobacter pylori infection and atherosclerosis: is there a causal relationship?

Authors:  Z Xu; J Li; H Wang; G Xu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-27       Impact factor: 3.267

Review 3.  Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.

Authors:  David Y Graham
Journal:  Gastroenterology       Date:  2015-02-02       Impact factor: 22.682

4.  The association of Helicobacter Pylori infection with dyslipidaemia and other atherogenic factors in dyspeptic patients at St. Paul's Hospital Millennium Medical College.

Authors:  Mujahid Hashim; Ousman Mohammed; Tatek G/Egzeabeher; Mistire Wolde
Journal:  Heliyon       Date:  2022-05-14

Review 5.  From the stomach to other organs: Helicobacter pylori and the liver.

Authors:  Marek Waluga; Michał Kukla; Michał Żorniak; Agata Bacik; Rafał Kotulski
Journal:  World J Hepatol       Date:  2015-08-28

6.  Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease.

Authors:  Myong Ki Baeg; Seung Kew Yoon; Sun-Hye Ko; Yong-Sun Noh; In-Seok Lee; Myung-Gyu Choi
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

Review 7.  Treatment of Helicobacter pylori infection: Current and future insights.

Authors:  Maliheh Safavi; Reyhaneh Sabourian; Alireza Foroumadi
Journal:  World J Clin Cases       Date:  2016-01-16       Impact factor: 1.337

8.  The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori.

Authors:  Albert Lecube; Silvia Valladares; Carolina López-Cano; Liliana Gutiérrez; Andreea Ciudin; José Manuel Fort; Josep Maria Reñé; Xavier Matias-Guiu; Inés de Torres; Marta Bueno; Judit Pallarés; Juan Antonio Baena
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

Review 9.  Metabolic Interaction of Helicobacter pylori Infection and Gut Microbiota.

Authors:  Yao-Jong Yang; Bor-Shyang Sheu
Journal:  Microorganisms       Date:  2016-02-16

Review 10.  Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders?

Authors:  Gracia M Martin-Nuñez; Isabel Cornejo-Pareja; Mercedes Clemente-Postigo; Francisco J Tinahones
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.